Factors influencing d3 vs d2 dopamine receptor subtype selectivity

被引：0
|
作者：
Luedtke, R. [1 ]
Hayatshahi, H. [2 ]
Griffin, S. [1 ]
Taylor, M. [1 ]
Xu, K. [2 ]
Liu, J. [2 ]
Mach, R. [3 ]
机构：
[1] Univ North Texas HSC, Pharmacol & Neurosci, Ft Worth, TX USA
[2] Univ North Texas, Coll Pharm, Pharmaceut Sci, Ft Worth, TX USA
[3] Univ Penn, Perelman Sch Med, Radiol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF NEUROCHEMISTRY | 2019年 / 150卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
WTH14-11
引用
收藏
页码：249 / 249
页数：1
相关论文
共 50 条
  • [1] Analogues of Arylamide Phenylpiperazine Ligands To Investigate the Factors Influencing D3 Dopamine Receptor Bitropic Binding and Receptor Subtype Selectivity
    Hayatshahi, Hamed S.
    Xu, Kuiying
    Griffin, Suzy A.
    Taylor, Michelle
    Mach, Robert H.
    Liu, Jin
    Luedtke, Robert R.
    ACS CHEMICAL NEUROSCIENCE, 2018, 9 (12): : 2972 - 2983
  • [2] Structural basis for dopamine D3 receptor subtype-selectivity
    Michino, Mayako
    Duan, Lihua
    Han, Yang
    Donthamsetti, Prashant
    Banala, Ashwini
    Newman, Amy H.
    Javitch, Jonathan A.
    Shi, Lei
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [3] Dopamine D2/D3 receptor availability and venturesomeness
    Bernow, Nina
    Yakushev, Igor
    Landvogt, Christian
    Buchholz, Hans-Georg
    Smolka, Michael N.
    Bartenstein, Peter
    Lieb, Klaus
    Gruender, Gerhard
    Vernaleken, Ingo
    Schreckenberger, Mathias
    Fehr, Christoph
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2011, 193 (02) : 80 - 84
  • [4] On dopamine D2 and D3 receptor pharmacology - Ekman,A
    不详
    NORDIC JOURNAL OF PSYCHIATRY, 1996, 50 (06) : 499 - 500
  • [5] Evaluation of Substituted N-Phenylpiperazine Analogs as D3 vs. D2 Dopamine Receptor Subtype Selective Ligands
    Lee, Boeun
    Taylor, Michelle
    Griffin, Suzy A.
    McInnis, Tamara
    Sumien, Nathalie
    Mach, Robert H.
    Luedtke, Robert R.
    MOLECULES, 2021, 26 (11):
  • [6] Effects of dopamine D3/D2 receptor agonists on body temperature and locomotion in dopamine D3 or D2 receptor knock-out mice
    Boulay, D
    Depoortere, R
    Perrault, G
    Sanger, DJ
    BRAIN RESEARCH, 1998, 809 (01) : A25 - A25
  • [7] Dopamine D3 vs D2 receptor antagonism: from transgenic models to therapeutic options
    Gross, G.
    Drescher, K. U.
    Bespalov, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S196 - S196
  • [8] Structure of the Human Dopamine D3 Receptor in Complex with a D2/D3 Selective Antagonist
    Chien, Ellen Y. T.
    Liu, Wei
    Zhao, Qiang
    Katritch, Vsevolod
    Han, Gye Won
    Hanson, Michael A.
    Shi, Lei
    Newman, Amy Hauck
    Javitch, Jonathan A.
    Cherezov, Vadim
    Stevens, Raymond C.
    SCIENCE, 2010, 330 (6007) : 1091 - 1095
  • [9] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Paul W. Czoty
    H. Donald Gage
    Pradeep K. Garg
    Sudha Garg
    Michael A. Nader
    Psychopharmacology, 2014, 231 : 613 - 619
  • [10] Effects of repeated treatment with the dopamine D2/D3 receptor partial agonist aripiprazole on striatal D2/D3 receptor availability in monkeys
    Czoty, Paul W.
    Gage, H. Donald
    Garg, Pradeep K.
    Garg, Sudha
    Nader, Michael A.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 613 - 619
12345